Segesterone Acetate And Ethinyl Estradiol + Atorvastatin Interaction
Unknowninteraction on record
Description
Substances Increasing the Systemic Exposure of CHCs and Potentially Increasing Exposure to Estrogen and/or Progestin in ANNOVERA : Co- administration of atorvastatin or rosuvastatin and certain CHCs containing EE increase systemic exposure of EE by approximately 20–25%.
Source: FDA drug label - segesterone acetate and ethinyl estradiol